Cellebrite DI Ltd.
NASDAQCLBT has recovered 5% this week to $13.35, but the stock is still down 26% year-to-date — and with Q1 earnings now just 12 days away on May 14, the options market is flashing a more cautious read than the week's price action suggests. Options positioning has shifted more defensive heading into the print. The put/call ratio is running at 0.30, about 1.4 standard deviations above its…
Snapshot as of 8 May 2026
CLBT has recovered 5% this week to $13.35, but the stock is still down 26% year-to-date — and with Q1 earnings now just 12 days away on May 14, the options market is flashing a more cautious read than the week's price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLBT — free to start on ORTEX.
Sign up for free →Open CLBT on ORTEX